Drug intelligence / Profile preview

CSA-8

Development stage
Preclinical
Lead developer
N8 Medical
Modality
Small Molecules
Administration
Topical
01

Overview

CSA-8 is a synthetic cationic steroid antibiotic (ceragenin) designed to mimic the physicochemical properties and biological activity of endogenous antimicrobial peptides (AMPs). Developed as a small molecule mimic of squalamine, CSA-8 features a cholic acid-based scaffold with strategically placed amino groups that render the molecule facially amphiphilic. This structure allows CSA-8 to selectively target and insert into the negatively charged membranes of bacteria and fungi, leading to rapid membrane depolarization, permeabilization, and cell death. Unlike traditional antibiotics that often target specific metabolic enzymes, CSA-8's membrane-disrupting mechanism of action makes it less susceptible to common bacterial resistance mechanisms. It has been primarily investigated for its broad-spectrum antimicrobial activity, particularly in the context of preventing biofilm formation on medical devices and treating topical infections.

Other names
Ceragenin CSA-8Cationic steroid antibiotic 8

Beyond the preview

Go deeper on CSA-8.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSA-8.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call